Adverse event reporting: NLP’s new niche?

Getting critical treatments approved and delivered to market is no easy feat. Currently, only 15% of drugs successfully make it from clinical trials to U.S. FDA approval—with nearly 75% of failures attributed to safety and efficacy concerns. Once drugs do […]

Read More

The beginnings of a ‘Covid-19’ industry

The Milken Institute, through its FasterCures effort, had set up a Covid-19 tracking system in late March to collect data on vaccines and therapies for the disease (and now there are multiple other efforts, including one from IQVIA). At that […]

Read More